Edgestream Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Edgestream Partners’s Portfolio SUPN Stock Details SUPN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.97M	Buy
2024 Q3	–	Sell
2024 Q2	$2.03M	Buy
2023 Q4	–	Sell
2023 Q3	$250K	Buy
2023 Q2	$219K	Buy